Article open access publication

Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib

Clinical Cancer Research, American Association for Cancer Research (AACR), ISSN 1557-3265

Volume 21, 12, 2015

DOI:10.1158/1078-0432.ccr-14-1813, Dimensions: pub.1052283288, PMID: 25398450,

Affiliations

Organisations

  1. (1) University Medical Center Utrecht, grid.7692.a
  2. (2) VU University Medical Center, grid.16872.3a
  3. (3) Genmab (Netherlands), grid.466767.2
  4. (4) Genmab (Denmark), grid.476284.b

Countries

Netherlands

Denmark

Continents

Europe

Funders

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Southern Denmark

Dimensions Citation Indicators

Times Cited: 81

Field Citation Ratio (FCR): 21.59

Relative Citation ratio (RCR): 3.81

Open Access Info

Bronze